ga

Skip to content

My Files [0]

These are the files you have added to your collection.

  • You don't have any documents yet, feel free to browse the website and add documents.

CADTH » Events » CADTH Symposium Archives » 2010 CADTH Symposium » Program Committee

Program Committee

Symposium Moderator

  • Mr. Peter Chinneck, Director, Partnerships and Strategic Initiatives, Canadian Agency for Drugs and Technologies in Health

Program Committee Members

  • Dr. Michael Allen, Director - Evidence-based Programs, Dalhousie University
  • Mr. David Ames, Director of Emerging Technologies and Health Economics, Johnson & Johnson Medical Products
  • Mr. Denis Bélanger, Director – COMPUS Topics and Research, Canadian Agency for Drugs and Technologies in Health
  • Mr. Jean-Marie Berthelot, Vice-President Programs, Canadian Institute for Health Information
  • Mr. Michel Boucher, Lead – HTA Development, Canadian Agency for Drugs and Technologies in Health
  • Mr. Ken Eng – Health Economist – CDR, Canadian Agency for Drugs and Technologies in Health
  • Ms. Jane Farquharson, Director – Knowledge Exchange and Liaison Program, Canadian Agency for Drugs and Technologies in Health
  • Ms. Lisa Farrell, Liaison Officer – Nova Scotia, Canadian Agency for Drugs and Technologies in Health
  • Ms. Hayley Fitzsimmons, Manager - Information Services, Canadian Agency for Drugs and Technologies in Health
  • Ms. Dawn Frail, Manager - Drug Technology Assessment, Nova Scotia Ministry of Health
  • Mr. David Fortier, Director - Strategy and Health Policy, Pfizer Canada
  • Ms. Penny Mohr, Vice-President – Programs, Centre for Medical Technology Policy
  • Mr. Jean Pruneau, Acting Executive Director, Health Canada – Office of Pharmaceuticals Management Strategies

Symposium Coordinators

  • Ms. Dale Calder, Events Planning Officer, Canadian Agency for Drugs and Technologies in Health
  • Ms. Donna Lachance, The Hillbrooke Group